logo

For the Inventor, By the Inventor

Cambridge, United Kingdom

Martin Bates

This inventor holds 2 USPTO granted patents. Top assignee: Metro International Biotech, LLC. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Bates. Retrieved from https://idiyas.com/inventor/martin-bates

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal2 out of 21 
 
Metro International Biotech, LLC
 patents

Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents
1. 11952396 - Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use (2024-04-09),
2. 11787830 - Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use (2023-10-17),

Title: Inventor Martin Bates

Introduction: Martin Bates is a renowned inventor based in Cambridge, GB, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Martin Bates holds several patents in the areas of renewable energy technologies, medical devices, and advanced materials, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Martin Bates has established himself as a leading figure in the innovation landscape, with numerous successful inventions that have had a significant impact on society.

Collaborations: Throughout his career, Martin Bates has collaborated with top research institutions, universities, and companies worldwide to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Martin Bates continues to push the boundaries of innovation, with his relentless drive to create solutions that address some of the most pressing challenges of our time, solidifying his legacy as a pioneering inventor in the global innovation community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…